ETC-168
ETC-168 is a selective and oral active MNK inhibitor with the IC50 values of 23 and 43 nM against MNK1 and MNK2, respectively. ETC-168 shows antiproliferative efficacy in vivo and in vitro[1].
Product Specifications
CAS Number
1464150-99-9
UNSPSC
12352005
Target
MNK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/etc-168.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(C2=CN=C3C=CC(C4=CC=C(C(N5CCOCC5)=O)C=C4)=NN32)C=C1
Molecular Formula
C24H19N5O2
Molecular Weight
409.44
References & Citations
[1]Ke XY, et al. MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma. Oncogene. 2021;40 (10) :1851-1867.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MNK1; MNK2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10431337 96 Well
Chicken Urinary bladder cancer antigen ELISA kit
Sign In for Pricing
View Details 
NBP2-80905 0.1 mL
Mouse Monoclonal PCNA Antibody (PC10) - Azide and BSA Free
Sign In for Pricing
View Details bs-2455R-BF488-TR 20 µL
CLEC7A Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details GTR15385937 1 Vial
Lentiviral human SERAC1 sgRNA gene knockout kit - Lentiviral human SERAC1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details ARP62290_P050 100 µL
NDUFB7 antibody - N-terminal region (ARP62290_P050)
Sign In for Pricing
View Details